Clinical Trials List
Protocol NumberGDC4950g
Not yet recruiting
2010-08-26 - 2015-05-01
Phase II
Terminated2
-
Trial Applicant
COVANCE TAIWAN SERVICES LIMITED
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 林建良 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 林明賢 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 馮盈勳 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 陳威宇 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tsu-Yi Chao Division of Hematology & Oncology
- 何景良 Division of Hematology & Oncology
- 高偉堯 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15-50 participants
-
Global
350 participants
